mosapramine has been researched along with Emesis in 2 studies
mosapramine: structure given in first source
mosapramine : A racemate comprising equimolar amounts of (R)- and (S)-mosapramine. It is a second-generation antipsychotic used for the treatment of schizophrenia.
1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(2-oxohexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-1'-yl)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| ")-induced vomiting in dogs, methamphetamine (2 mg/kg, s." | 3.67 | [Neuroleptic properties of Y-516, a new iminodibenzyl derivative]. ( Fukuda, T; Maruyama, Y; Morimoto, Y; Setoguchi, M; Shoji, H; Tsumagari, T, 1985) |
| "Mosapramine (1) is a new neuroleptic drug with an asymmetric carbon atom (8a) in its imidazopyridine ring." | 1.29 | Syntheses and biological activities of optical isomers of 3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a]pyridine- 3-spiro-4'-piperidino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine (mosapramine) dihydrochloride. ( Fukuda, T; Marubayashi, N; Setoguchi, S; Tashiro, C, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tashiro, C | 1 |
| Setoguchi, S | 1 |
| Fukuda, T | 2 |
| Marubayashi, N | 1 |
| Setoguchi, M | 1 |
| Morimoto, Y | 1 |
| Shoji, H | 1 |
| Tsumagari, T | 1 |
| Maruyama, Y | 1 |
2 other studies available for mosapramine and Emesis
| Article | Year |
|---|---|
Syntheses and biological activities of optical isomers of 3-chloro-5-[3-(2-oxo-1,2,3,5,6,7,8,8a-octahydroimidazo[1,2-a]pyridine- 3-spiro-4'-piperidino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine (mosapramine) dihydrochloride.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzazepines; Dogs; Drug Interactions; | 1993 |
[Neuroleptic properties of Y-516, a new iminodibenzyl derivative].
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Corpus Striatum; Dogs; Female; Hydroxydopa | 1985 |